Clinical Trials Browser

Interventional × Ovarian Neoplasms × lifastuzumab vedotin × Clear all

NCT01991210 2017-08-21

A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)

Phase 2 Terminated

Ovarian Neoplasms